Las Vegas, NV - (NewMediaWire) - September 15, 2020 - One World Pharma Inc. (OTC: OWPC), “OWP,” a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is pleased to announce that its Chief Executive Officer, Isiah Thomas, will host a live Investor Presentation this Friday, September 18, 2020 at 4:30 EST via Zoom. Executive Chairman Dr. Kenneth Perego and Board Member Bruce Raben will be in attendance as well.
Date/Time: Sep 18, 2020, 04:30 PM Eastern Standard Time (US and Canada)
One World Pharma Investor Call
Reserve your space today:
Investors are encouraged to send their questions for Mr. Thomas and the team in advance to email@example.com.
All questions will be considered and Mr. Thomas and team will answer as many as possible during the presentation.
“One World Pharma has just entered an exciting phase for this Company as our harvests are now producing revenue,” said Thomas. “Much has changed over the past few months and it’s time for a wholesale update about the challenges we’ve overcome, the long strides we’ve made, and our near-term vision to establish One World Pharma as a leading international supplier of the finest cannabis ingredients.”
About One World Pharma
Formed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp-derived ingredients for use in the manufacturing of Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for chemical formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia.
One World Pharma Investor Relations & Financial Media
Kurt Divich, CEO
Integrity Media Inc.
Toll Free: (888) 216-3595
Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 29, 2020, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.